Cargando…
Therapies for Neovascular Age-Related Macular Degeneration: Current Approaches and Pharmacologic Agents in Development
As one of the leading causes of blindness, age-related macular degeneration (AMD) has remained at the epicenter of clinical research in ophthalmology. During the past decade, focus of researchers has ranged from understanding the role of vascular endothelial growth factor (VEGF) in the angiogenic ca...
Autores principales: | Hanout, Mostafa, Ferraz, Daniel, Ansari, Mehreen, Maqsood, Natasha, Kherani, Saleema, Sepah, Yasir J., Rajagopalan, Nithya, Ibrahim, Mohamed, Do, Diana V., Nguyen, Quan Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844201/ https://www.ncbi.nlm.nih.gov/pubmed/24319688 http://dx.doi.org/10.1155/2013/830837 |
Ejemplares similares
-
Variation of choroidal thickness and vessel diameter in patients with posterior non-infectious uveitis
por: Bittencourt, Millena G, et al.
Publicado: (2014) -
Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development
por: Agarwal, Aniruddha, et al.
Publicado: (2015) -
Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
por: Sadiq, Mohammad Ali, et al.
Publicado: (2015) -
Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases
por: Sophie, Raafay, et al.
Publicado: (2012) -
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate
por: Ibrahim, Mohamed A, et al.
Publicado: (2013)